Aktiesnakken — September 2009
-
Hun tror meget på CLL i 1st line
-
fordi patienterne ofte er gamle og ikke kan tåle aggressiv kemo
-
Nu zalutumab, resultater skal komme inden year end
-
Vi har worldwide rights, kigger på partnerskab, når resultaterne foreligger
-
Upcoming milestones
-
Ash mere data på CLL og NHL
-
Big milestones på Approval
-
We are building for the future!
-
Vi håber at lave partnerskab på EGFR når data kommer
-
Enten er der ingen spørgsmål, eller også var der ingen.
-
Hørte nogen om han bad om spørgsmål?
-
16-timens nyt i HH-sagaen.... : https://newsclient.omxgroup.com/cds/DisclosureAttachmentServlet?messageAttachmentId=276814
-
dog mest blot sammenskrivning af dagens avisartikler..... men dog fra officiel side så at sige
-
flot ingeniørarbejde, ikk' stengård?, http://pleasure.dk/shopping/artikel/166405/
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind